Quantum-si vs YD Bio
Quantum-si is the larger business, with $2.4m of revenue in fiscal 2025 against $596,817 for YD Bio (4.1 times as much). YD Bio grew faster (16.9% against -20.3%). YD Bio kept more of each dollar of sales as profit: a net margin of -1392.6% against -4160.1%.
| Latest fiscal year | Quantum-siQSI, 2025 | YD BioYDES, 2025 |
|---|---|---|
| Revenue | $2.4m | $596,817 |
| Revenue growth | -20.3% | 16.9% |
| Net income | −$101m | −$8.3m |
| Operating margin | — | -883.3% |
| Net margin | -4160.1% | -1392.6% |
| Return on equity | -46.5% | — |
| Free cash flow | −$97.2m | −$8.0m |
| Cash | $21.6m | $6.0m |
| Total debt | $0 | $6,764 |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 138 | — |
| Market value | $281m | $446m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 2 buys, 30 sales | 3 buys, 0 sales |